Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

NCT00161668 · clinicaltrials.gov ↗

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Mylotarg

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer